Curia global

Index
Globenewswire

Curia Umumkan Pembiayaan Ulang (Refinancing) Strategis untuk Mendukung Pertumbuhan yang Berkelanjutan

Globenewswire

Curia Announces Strategic Refinancing to Support Continued Growth

Globenewswire

Curia Menetapkan Komitmen Terhadap Standar Nol Bersih SBTi

Globenewswire

Curia Ungkap Identitas Merek yang Disegarkan di CPHI WW di Milan

Globenewswire

Curia Commits to SBTi Net-Zero Standard

Globenewswire

Curia Unveils Brand Refresh at CPHI WW in Milan

Globenewswire

Curia dan Carterra Bermitra untuk Mengadakan Simposium Biologik guna Meningkatkan Riset Bioteknologi di Pasifik Barat Laut

Globenewswire

Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest

Globenewswire

Curia Mengangkat Steve Lavezoli sebagai Wakil Presiden, Divisi Biologik

Globenewswire

Curia Appoints Steve Lavezoli as Vice President, Biologics

Globenewswire

Curia Receives 2024 CDMO Leadership Award

Globenewswire

Curia Menerima Penghargaan Kepemimpinan CDMO 2024

Globenewswire

Curia Mengangkat Gerald Auer sebagai Chief Financial Officer

Globenewswire

Curia Appoints Gerald Auer as Chief Financial Officer

Globenewswire

Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India

Globenewswire

Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine

Globenewswire

Curia Mendukung Uji Klinis Fase 1 Vaksin RNA Generasi Terbaru dari Replicate Bioscience

Globenewswire

Curia Tngkatkan Kemampuan Biologis dengan Akses ke Doggybone DNA dari Touchlight

Globenewswire

Curia Expands Biologics Capabilities with Access to Touchlight’s Doggybone DNA

Globenewswire

Curia Wins 2023 Frost & Sullivan Customer Value Leadership Award

Globenewswire

Curia Raih Penghargaan Customer Value Leadership 2023 dari Frost & Sullivan

Globenewswire

Curia Expands Cell Line Development Offering with CHOZN Platform

Globenewswire

Curia Perluas Penawaran Pengembangan Galur Sel dengan Platform CHOZN